Cargando…
p53/p21 Pathway Involved in Mediating Cellular Senescence of Bone Marrow-Derived Mesenchymal Stem Cells from Systemic Lupus Erythematosus Patients
Our and other groups have found that bone marrow-derived mesenchymal stem cells (BM-MSCs) from systemic lupus erythematosus (SLE) patients exhibited senescent behavior and are involved in the pathogenesis of SLE. Numerous studies have shown that activation of the p53/p21 pathway inhibits the prolife...
Autores principales: | Gu, Zhifeng, Jiang, Jinxia, Tan, Wei, Xia, Yunfei, Cao, Haixia, Meng, Yan, Da, Zhanyun, Liu, Hong, Cheng, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787636/ https://www.ncbi.nlm.nih.gov/pubmed/24151513 http://dx.doi.org/10.1155/2013/134243 |
Ejemplares similares
-
Rapamycin reverses the senescent phenotype and improves immuno-regulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway
por: Gu, Zhifeng, et al.
Publicado: (2016) -
Cooperation between p21 and Akt is required for p53‐dependent cellular senescence
por: Kim, Young Yeon, et al.
Publicado: (2017) -
Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells
por: Ji, Juan, et al.
Publicado: (2019) -
Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections
por: Lu, Zhimin, et al.
Publicado: (2019) -
Role of p53 in the Regulation of Cellular Senescence
por: Mijit, Mahmut, et al.
Publicado: (2020)